Eight senators want the Drug Enforcement Administration (DEA) to revive a limit it proposed but never imposed and ban a drug it already bans.
asserted
it → want → drug
Their letter urges the agency to undo changes it has only proposed.
asserted
it → urge → changes
"Kratom is an opioid," the senators begin.
asserted
senators → begin → ?
Some compounds in kratom activate the same receptor as morphine.
asserted
compounds → activate → morphine
But that doesn't mean all kratom products are alike.
asserted
products → mean → ?
Kratom leaves contain trace amounts of 7-hydroxymitragynine (7-OH), but a cup of kratom tea and a tablet containing concentrated 7-OH can deliver very different amounts of the compound.
asserted
cup → contain → compound
The senators' label glosses over a difference that matters when the government decides what to ban.
asserted
government → gloss → what
A new review from Reason Foundation, the nonprofit that publishes Reason, describes how people have long used kratom to manage pain and ease opioid withdrawal.
asserted
people → publish → withdrawal
In a survey, users reported taking kratom for anxiety, for pain while trying to avoid conventional opioids, or to cut back on or stop taking other opioids.
asserted
users → report → opioids
In a letter to the Department of Health and Human Services, nine military veterans described using concentrated 7-OH to manage pain and symptoms of post-traumatic stress disorder and to move away from other opioids or alcohol.
asserted
veterans → describe → opioids
These accounts tell us why people seek out these products.
asserted
people → tell → products
Whether the products reliably help them remains a question for researchers.
asserted
help → help → researchers
In July, the DEA proposed putting 7-OH in Schedule I, a federal classification that generally makes possession a crime, if the compound makes up more than 0.05 percent of a product by weight.
asserted
compound → propose → weight
That proposal never took effect.
asserted
proposal → take → effect
In August, the agency issued an order putting a related compound, mitragynine pseudoindoxyl (MP), in Schedule I regardless of its concentration.
asserted
agency → issue → concentration
On October 14, the DEA proposed new limits.
asserted
DEA → propose → limits
Under the proposal, Schedule I controls would apply to solid products containing more than 0.1 percent 7-OH or MP by weight, counting both together if a product contains both.
asserted
product → apply → both
The proposal sets a separate concentration limit for liquids.
asserted
proposal → set → liquids
It also requires at least 100 parts mitragynine, the main active compound in natural kratom, for every part of 7-OH and MP combined.
asserted
It → require → OH
A product could fall below the concentration limit and still trigger Schedule I controls if it failed that second test.
uncertain
it → fall → test
The DEA said it would publish an order on or after November 13.
asserted
it → say → November
That was the earliest date the agency could publish the order.
uncertain
agency → publish → order
The limits did not take effect automatically on that date, and the October notice left the August order on MP in place.
asserted
notice → take → place
As of November 19, the DEA had yet to publish an order putting the new limits into effect.
asserted
DEA → have → effect
In their November 16 letter to the DEA and the Food and Drug Administration (FDA), Sen. Charles Grassley (R–Iowa) and seven colleagues said the DEA had doubled the previously allowable concentration of 7-OH and removed MP from Schedule I.
asserted
DEA → say → MP
The senators got the arithmetic right for solids: 0.1 percent is twice 0.05 percent.
asserted
percent → get → solids
But the July and October figures both came from proposals.
asserted
figures → come → proposals
And the October proposal would keep MP under Schedule I controls in products that exceed either threshold.
asserted
that → keep → threshold
Asking the FDA to explain why health officials recommended a higher cutoff is reasonable.
asserted
officials → ask → cutoff
Demanding that the DEA restore a ban it hasn't lifted is something else.
asserted
it → demand → ban
A concentration limit tells us surprisingly little about the dose someone takes.
asserted
someone → tell → dose
Two tablets of different sizes can contain the same amount of 7-OH, even if one crosses the concentration limit and the other falls below it.
asserted
other → contain → it
The DEA acknowledges that controlled human trials have yet to establish safe consumption limits for concentrated 7-OH.
asserted
trials → acknowledge → OH
What evidence shows that the senators' preferred cutoff would make consumers safer?
asserted
consumers → show → ?
What evidence would justify prosecuting adults for possessing a product that crosses it?
asserted
that → justify → it
Federal law reserves Schedule I for substances deemed to have a "high potential for abuse" and "no currently accepted medical use in treatment in the United States," among other criteria.
asserted
law → reserve → criteria
Congress also gave the DEA power to place substances there temporarily when the agency finds an imminent hazard to public safety.
asserted
agency → give → safety
Health officials supplied the proposed thresholds in this case.
asserted
officials → supply → case
The DEA decides whether to impose them.
asserted
DEA → decide → them
Federal drug police already decide what adults can take to manage pain or cope with withdrawal.
asserted
adults → decide → withdrawal
…and 11 more, not listed.